# Identification of potential ferroptosis-related biomarkers in proliferative vitreoretinopathy based on machine learning

**Authors:** Jiangying Liu, Shengxiang Zhang, Lingdan Wu, Yingchao Xue, Boyu Liu, Hongyan Song, Qihua Xu

PMC · DOI: 10.3389/fmolb.2026.1725407 · Frontiers in Molecular Biosciences · 2026-02-10

## TL;DR

This study identifies TIMP1 and STAT3 as potential ferroptosis-related biomarkers in proliferative vitreoretinopathy, linking them to immune changes and disease progression.

## Contribution

Novel identification of ferroptosis-related genes TIMP1 and STAT3 as potential biomarkers for PVR, linking them to immune infiltration and oxidative stress pathways.

## Key findings

- TIMP1 and STAT3 show strong discriminative ability between PVR and control samples.
- TIMP1 and STAT3 expression correlates with immune cell subsets in PVR.
- GPX4 protein is upregulated in a rabbit PVR model compared to controls.

## Abstract

Proliferative vitreoretinopathy (PVR) is a blinding retinal condition often linked to retinal detachment, eye trauma, and complications following intraocular surgery. Although oxidative stress and epithelial–mesenchymal transition (EMT) are well-recognized contributors to PVR pathogenesis, whether ferroptosis-related pathways are involved in this process remains unclear.

Differentially expressed genes (DEGs) were identified from the GSE28133 dataset and intersected with ferroptosis-related genes curated from FerrDb to obtain ferroptosis-related differentially expressed genes (FRDGs). Functional enrichment analyses, protein–protein interaction network construction, and machine learning approaches (LASSO regression and SVM-RFE) were applied to identify key candidate genes. Immune infiltration was analyzed using CIBERSORT. Experimental validation was performed using an in vitro EMT model of retinal pigment epithelial cells and a rabbit PVR model.

Functional enrichment analyses indicated that FRDGs were mainly involved in wound healing, tissue remodeling, oxidative stress responses, and ferroptosis-related pathways. TIMP1 and STAT3 were identified as ferroptosis-associated candidate genes with strong discriminative ability between PVR and control samples in the discovery dataset. Immune infiltration analysis revealed distinct immune cell profiles in PVR samples and significant correlations between TIMP1 and STAT3 expression and multiple immune cell subsets. Experimental validation confirmed upregulation of TIMP1 and STAT3 in the EMT model. In addition, Western blot analysis demonstrated significantly increased GPX4 protein expression in retinal tissues from the rabbit PVR model compared with controls.

This study identifies TIMP1 and STAT3 as ferroptosis-associated candidate genes in proliferative vitreoretinopathy and highlights potential links among ferroptosis-related regulatory pathways, immune microenvironment alterations, and PVR pathogenesis. These findings provide a foundation for further mechanistic studies to clarify the role of ferroptosis in PVR.

## Linked entities

- **Genes:** TIMP1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 7076], STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774], GPX4 (glutathione peroxidase 4) [NCBI Gene 2879]
- **Proteins:** GPX4 (glutathione peroxidase 4)
- **Diseases:** proliferative vitreoretinopathy (MONDO:0100450), retinal detachment (MONDO:0008375)

## Full-text entities

- **Genes:** CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CAV1 (caveolin 1) [NCBI Gene 857] {aka BSCL3, CGL3, LCCNS, MSTP085, PPH3, VIP21}, PVR (PVR cell adhesion molecule) [NCBI Gene 5817] {aka CD155, HVED, NECL5, Necl-5, PVS, TAGE4}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CP (ceruloplasmin) [NCBI Gene 1356] {aka AB073614, CP-2}, BLNK (B cell linker) [NCBI Gene 29760] {aka AGM4, BASH, BLNK-S, LY57, SLP-65, SLP65}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, FZD7 (frizzled class receptor 7) [NCBI Gene 8324] {aka FzE3}, DRD4 (dopamine receptor D4) [NCBI Gene 1815] {aka D4DR}, CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 1026] {aka CAP20, CDKN1, CIP1, MDA-6, P21, SDI1}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, FTL (ferritin light chain) [NCBI Gene 2512] {aka FTL1, LFTD, NBIA3}, TIMP1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 7076] {aka CLGI, EPA, EPO, HCI, TIMP, TIMP-1}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, TGFB2 (transforming growth factor beta 2) [NCBI Gene 7042] {aka CAEND2, G-TSF, LDS4, TGF-beta2}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, EPO (erythropoietin) [NCBI Gene 2056] {aka DBAL, ECYT5, EP, MVCD2}, ARNT (aryl hydrocarbon receptor nuclear translocator) [NCBI Gene 405] {aka ARNT1, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, PARP9 (poly(ADP-ribose) polymerase family member 9) [NCBI Gene 83666] {aka ARTD9, BAL, BAL1, MGC:7868}
- **Diseases:** fibrosis (MESH:D005355), inflammation (MESH:D007249), ocular trauma (MESH:D014947), disease (MESH:D004194), eye trauma (MESH:D009104), diabetic (MESH:D003920), PVR (MESH:D018630), age-related macular degeneration (MESH:D008268), hypoxic (MESH:D002534), RD (MESH:D012163), hypoxia (MESH:D000860), atherosclerosis (MESH:D050197), FRDGs (MESH:D001039), diabetic retinopathy (MESH:D003930), retinal disorder (MESH:D012173), tumor cardiovascular diseases (MESH:D002318), corneal alkali burns (MESH:D006934), retinal condition (MESH:D012164), glaucoma (MESH:D005901), ocular diseases (MESH:D005128), overdose (MESH:D062787)
- **Chemicals:** pentobarbital sodium (MESH:D010424), lipid peroxides (MESH:D008054), streptomycin (MESH:D013307), TRIzol (MESH:C411644), iron (MESH:D007501), SDS (MESH:D012967), DMEM/F12 medium (-), penicillin (MESH:D010406), ketamine hydrochloride (MESH:D007649), glutathione (MESH:D005978), CO2 (MESH:D002245), agarose (MESH:D012685), lipid (MESH:D008055), PVDF (MESH:C024865), reactive oxygen species (MESH:D017382)
- **Species:** Homo sapiens (human, species) [taxon 9606], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986]
- **Cell lines:** RPE — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_IQ82), ARPE-19 — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0145)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12930359/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12930359/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12930359/full.md

---
Source: https://tomesphere.com/paper/PMC12930359